| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net cash (used in) provided by financing activities | -41,294 | -35,970 | -4,198 | 221,396 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -383,537 | -255,635 | -138,255 | 184,093 |
| Cash and cash equivalents at beginning of period | 836,980 | 836,980 | 836,980 | 69,709 |
| Cash and cash equivalents at end of period | 453,443 | 581,345 | 698,725 | 253,802 |
Core Scientific, Inc. tx (CORZ)
Core Scientific, Inc. tx (CORZ)